Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 1;28(2):95-103.
doi: 10.1097/MOT.0000000000001054. Epub 2023 Feb 7.

Using organ perfusion to optimize donor livers

Grace S Lee-Riddle  1 , Guergana G Panayotova, James V Guarrera
Affiliations
Review

Using organ perfusion to optimize donor livers

Grace S Lee-Riddle et al. Curr Opin Organ Transplant. .

Abstract

Purpose of review: The shortage of donor organs has led to the use of marginal extended criteria donor (ECD) livers to increase access to liver transplant. Ex-vivo machine perfusion allows for treatment and assessment of organs during preservation, potentially facilitating safe use of ECD livers at risk for worse clinical outcomes. This article reviews the latest published literature on the application of ex-vivo machine perfusion technologies in liver transplantation.

Recent findings: Multiple randomized controlled trials on the use of hypothermic machine perfusion (HMP) and normothermic machine perfusion (NMP) have been published in the past 5 years demonstrating improved graft function and decreased biliary complications after machine perfusion. Novel applications of machine perfusion include pretransplant organ viability testing, expansion to pediatric transplant, and prolonged preservation.

Summary: There is now a body of evidence that HMP and NMP treatment improves clinical outcomes in ECD livers. There is a wide horizon for future applications of these preservation techniques to further optimize donor livers and to facilitate more liver transplants for those on the waitlist.

PubMed Disclaimer

References

    1. Organ Procurement and Transplantation Network. National Data [Internet]. Health Resources and Services Administration, US Department of Health and Human Services; 2022 [cited 2022 Dec 30]. Available from: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/ .
    1. Attia M, Silva MA, Mirza DF. The marginal liver donor--an update. Transpl Int 2008; 21:713–724.
    1. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6:783–790.
    1. Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl 2010; 16:943–949.
    1. Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg 2011; 253:259–264.